Clinical trial
Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II…
NCT00237952 · Chang Gung Memorial Hospital, Other · Completed
Key facts
| NCT number | NCT00237952 |
|---|---|
| Title | Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy |
| Official title | Environmental Lead Exposure and Progressive Renal Insufficiency in Patients With Type II Diabetes and Diabetic Nephropathy |
| Lead sponsor | Chang Gung Memorial Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Nephropathies, Diabetes Mellitus, Type II |
| Intervention type | Drug |
| Interventions | EDTA chelating agents |
| Start date | Aug 1, 2005 |
| First posted | Oct 13, 2005 |
| Last update posted | Jun 23, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: